EUVIMEDEUVIMED entdecken
ValidierungsstudieQualitative StudieOpen Access · CC BY-NC 4.0

Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview study

Allison Martin Nguyen iD, Carmen La Rosa, Alexandra G Cornell, Mandel R Sher, Jonathan A Bernstein, Surinder S Birring, Carla DeMuro Romano, Margaret Mayorga, Mirline Milien, Claire Ervin iD

Therapeutic Advances in Respiratory Disease · 2024

DOI: 10.1177/17534666241274261 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2024. Verfasst von Allison Martin Nguyen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Merck & Co., Inc., Rahway, NJ, USA. Hauptthemen laut MEDLINE: Cough, Patient Reported Outcome Measures, Interviews as Topic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic cough, a cough lasting >8 weeks, includes refractory chronic cough (RCC) and unexplained chronic cough (UCC). Patient-reported outcome (PRO) measures are needed to better understand chronic cough impacts that matter most to patients. The 19-item Leicester Cough Questionnaire (LCQ), an existing PRO measure of chronic cough, assesses impacts of cough across physical, psychological, and social domains. However, the content validity of the LCQ evaluating these concepts in patients with RCC/UCC had not been established.

Objectives

To evaluate the content validity of the LCQ in patients with RCC/UCC.

Design

A cross-sectional, qualitative interview study.

Methods

First, previously completed qualitative interview results in adults with RCC/UCC ( N = 30) were evaluated and mapped to LCQ concepts. Next, a clinical cough expert reviewed each LCQ item and assessed the salience of its concepts for patients with RCC/UCC. Finally, semistructured interviews—including both concept elicitation and cognitive debriefing—were conducted in adults with RCC/UCC ( N = 20) to elicit a comprehensive set of participant experiences and to assess the appropriateness of using the LCQ in this population.

Results

Concepts reported in the past and present qualitative interviews were included across all LCQ items, and most impacts reported to be the “most bothersome” were assessed in the LCQ. In the current study, all participants indicated that reduced cough frequency would be an important treatment target. During cognitive debriefing, each LCQ item was endorsed by ⩾70% of participants. Additionally, participants were generally able to understand, recall, and select a response for each LCQ item. All participants and the clinical expert indicated that the LCQ was appropriate and assessed the impacts most relevant to patients with RCC/UCC.

Conclusion

Our findings support the content validity of the LCQ and demonstrate that this measure is fit-for-purpose and includes important cough impacts in adults with RCC/UCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoughPatient Reported Outcome MeasuresInterviews as TopicHumansMaleFemaleMiddle AgedChronic DiseaseCross-Sectional StudiesAdultAgedReproducibility of ResultsQualitative ResearchSurveys and QuestionnairesQuality of LifePredictive Value of TestsChronic Cough

Stichwörter der Autor:innen

Leicester Cough Questionnairechronic coughcontent validitycough-specific health-related quality of lifepatient-reported outcomequalitative interviewsrefractory chronic coughunexplained chronic cough

Autor:innen und Institutionen

  • Merck & Co., Inc., Rahway, NJ, USA.
  • Center for Cough, Largo, FL, USA.
  • Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Bernstein Clinical Research Center, LLC, Cincinnati, OH, USA.
  • Centre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • RTI Health Solutions, Research Triangle Park, NC, USA.

ORCID-Profile: Allison Martin Nguyen, Claire Ervin

Förderung

  • Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA

Zitieren

APA

Martin Nguyen, A., La Rosa, C., Cornell, A. G., Sher, M. R., Bernstein, J. A., Birring, S. S., DeMuro Romano, C., Mayorga, M., Milien, M., & Ervin, C. (2024). Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview study. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666241274261

Vancouver

Martin Nguyen A, La Rosa C, Cornell AG, Sher MR, Bernstein JA, Birring SS, et al. Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview study. Therapeutic Advances in Respiratory Disease. 2024. doi:10.1177/17534666241274261

BibTeX
@article{MartinNguyen2024,
  author = {Martin Nguyen, Allison and La Rosa, Carmen and Cornell, Alexandra G and Sher, Mandel R and Bernstein, Jonathan A and Birring, Surinder S and DeMuro Romano, Carla and Mayorga, Margaret and Milien, Mirline and Ervin, Claire},
  title = {Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview study},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2024},
  doi = {10.1177/17534666241274261}
}
Kostenlos starten →